1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Crizotinib 1.2.3 Alectinib 1.2.4 Ceritinib 1.2.5 Brigatinib 1.2.6 Other 1.3 Market by Application 1.3.1 Global ALK Positive Lung Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinics 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global ALK Positive Lung Cancer Treatment Market Perspective (2016-2027) 2.2 ALK Positive Lung Cancer Treatment Growth Trends by Regions 2.2.1 ALK Positive Lung Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 ALK Positive Lung Cancer Treatment Historic Market Share by Regions (2016-2021) 2.2.3 ALK Positive Lung Cancer Treatment Forecasted Market Size by Regions (2022-2027) 2.3 ALK Positive Lung Cancer Treatment Industry Dynamic 2.3.1 ALK Positive Lung Cancer Treatment Market Trends 2.3.2 ALK Positive Lung Cancer Treatment Market Drivers 2.3.3 ALK Positive Lung Cancer Treatment Market Challenges 2.3.4 ALK Positive Lung Cancer Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top ALK Positive Lung Cancer Treatment Players by Revenue 3.1.1 Global Top ALK Positive Lung Cancer Treatment Players by Revenue (2016-2021) 3.1.2 Global ALK Positive Lung Cancer Treatment Revenue Market Share by Players (2016-2021) 3.2 Global ALK Positive Lung Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by ALK Positive Lung Cancer Treatment Revenue 3.4 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio 3.4.1 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by ALK Positive Lung Cancer Treatment Revenue in 2020 3.5 ALK Positive Lung Cancer Treatment Key Players Head office and Area Served 3.6 Key Players ALK Positive Lung Cancer Treatment Product Solution and Service 3.7 Date of Enter into ALK Positive Lung Cancer Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 ALK Positive Lung Cancer Treatment Breakdown Data by Type 4.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Type (2016-2021) 4.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2022-2027) 5 ALK Positive Lung Cancer Treatment Breakdown Data by Application 5.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Application (2016-2021) 5.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America ALK Positive Lung Cancer Treatment Market Size (2016-2027) 6.2 North America ALK Positive Lung Cancer Treatment Market Size by Type 6.2.1 North America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) 6.2.2 North America ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) 6.2.3 North America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2027) 6.3 North America ALK Positive Lung Cancer Treatment Market Size by Application 6.3.1 North America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) 6.3.2 North America ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) 6.3.3 North America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2027) 6.4 North America ALK Positive Lung Cancer Treatment Market Size by Country 6.4.1 North America ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021) 6.4.2 North America ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe ALK Positive Lung Cancer Treatment Market Size (2016-2027) 7.2 Europe ALK Positive Lung Cancer Treatment Market Size by Type 7.2.1 Europe ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) 7.2.2 Europe ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) 7.2.3 Europe ALK Positive Lung Cancer Treatment Market Size by Type (2016-2027) 7.3 Europe ALK Positive Lung Cancer Treatment Market Size by Application 7.3.1 Europe ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) 7.3.2 Europe ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) 7.3.3 Europe ALK Positive Lung Cancer Treatment Market Size by Application (2016-2027) 7.4 Europe ALK Positive Lung Cancer Treatment Market Size by Country 7.4.1 Europe ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021) 7.4.2 Europe ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size (2016-2027) 8.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type 8.2.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application 8.3.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region 8.4.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America ALK Positive Lung Cancer Treatment Market Size (2016-2027) 9.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Type 9.2.1 Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) 9.2.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) 9.2.3 Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2027) 9.3 Latin America ALK Positive Lung Cancer Treatment Market Size by Application 9.3.1 Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) 9.3.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) 9.3.3 Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2027) 9.4 Latin America ALK Positive Lung Cancer Treatment Market Size by Country 9.4.1 Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021) 9.4.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size (2016-2027) 10.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type 10.2.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application 10.3.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country 10.4.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 F. Hoffmann-La Roche 11.1.1 F. Hoffmann-La Roche Company Details 11.1.2 F. Hoffmann-La Roche Business Overview 11.1.3 F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Introduction 11.1.4 F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) 11.1.5 F. Hoffmann-La Roche Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview 11.2.3 Pfizer ALK Positive Lung Cancer Treatment Introduction 11.2.4 Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) 11.2.5 Pfizer Recent Development 11.3 Novartis 11.3.1 Novartis Company Details 11.3.2 Novartis Business Overview 11.3.3 Novartis ALK Positive Lung Cancer Treatment Introduction 11.3.4 Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) 11.3.5 Novartis Recent Development 11.4 TP Therapeutics 11.4.1 TP Therapeutics Company Details 11.4.2 TP Therapeutics Business Overview 11.4.3 TP Therapeutics ALK Positive Lung Cancer Treatment Introduction 11.4.4 TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) 11.4.5 TP Therapeutics Recent Development 11.5 Bristol-Myers Squibb 11.5.1 Bristol-Myers Squibb Company Details 11.5.2 Bristol-Myers Squibb Business Overview 11.5.3 Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Introduction 11.5.4 Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) 11.5.5 Bristol-Myers Squibb Recent Development 11.6 Eli Lilly and Company 11.6.1 Eli Lilly and Company Company Details 11.6.2 Eli Lilly and Company Business Overview 11.6.3 Eli Lilly and Company ALK Positive Lung Cancer Treatment Introduction 11.6.4 Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) 11.6.5 Eli Lilly and Company Recent Development 11.7 Takeda 11.7.1 Takeda Company Details 11.7.2 Takeda Business Overview 11.7.3 Takeda ALK Positive Lung Cancer Treatment Introduction 11.7.4 Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) 11.7.5 Takeda Recent Development 11.8 Beacon Pharma 11.8.1 Beacon Pharma Company Details 11.8.2 Beacon Pharma Business Overview 11.8.3 Beacon Pharma ALK Positive Lung Cancer Treatment Introduction 11.8.4 Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) 11.8.5 Beacon Pharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Crizotinib Table 3. Key Players of Alectinib Table 4. Key Players of Ceritinib Table 5. Key Players of Brigatinib Table 6. Key Players of Other Table 7. Global ALK Positive Lung Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global ALK Positive Lung Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global ALK Positive Lung Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global ALK Positive Lung Cancer Treatment Market Share by Regions (2016-2021) Table 11. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global ALK Positive Lung Cancer Treatment Market Share by Regions (2022-2027) Table 13. ALK Positive Lung Cancer Treatment Market Trends Table 14. ALK Positive Lung Cancer Treatment Market Drivers Table 15. ALK Positive Lung Cancer Treatment Market Challenges Table 16. ALK Positive Lung Cancer Treatment Market Restraints Table 17. Global ALK Positive Lung Cancer Treatment Revenue by Players (2016-2021) & (US$ Million) Table 18. Global ALK Positive Lung Cancer Treatment Market Share by Players (2016-2021) Table 19. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2020) Table 20. Ranking of Global Top ALK Positive Lung Cancer Treatment Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by ALK Positive Lung Cancer Treatment Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players ALK Positive Lung Cancer Treatment Product Solution and Service Table 24. Date of Enter into ALK Positive Lung Cancer Treatment Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 27. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2016-2021) Table 28. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global ALK Positive Lung Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Application (2016-2021) Table 32. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 35. North America ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 36. North America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 37. North America ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 38. North America ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) Table 39. North America ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 41. Europe ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 43. Europe ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) Table 64. F. Hoffmann-La Roche Company Details Table 65. F. Hoffmann-La Roche Business Overview Table 66. F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Product Table 67. F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million) Table 68. F. Hoffmann-La Roche Recent Development Table 69. Pfizer Company Details Table 70. Pfizer Business Overview Table 71. Pfizer ALK Positive Lung Cancer Treatment Product Table 72. Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million) Table 73. Pfizer Recent Development Table 74. Novartis Company Details Table 75. Novartis Business Overview Table 76. Novartis ALK Positive Lung Cancer Treatment Product Table 77. Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million) Table 78. Novartis Recent Development Table 79. TP Therapeutics Company Details Table 80. TP Therapeutics Business Overview Table 81. TP Therapeutics ALK Positive Lung Cancer Treatment Product Table 82. TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million) Table 83. TP Therapeutics Recent Development Table 84. Bristol-Myers Squibb Company Details Table 85. Bristol-Myers Squibb Business Overview Table 86. Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Product Table 87. Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million) Table 88. Bristol-Myers Squibb Recent Development Table 89. Eli Lilly and Company Company Details Table 90. Eli Lilly and Company Business Overview Table 91. Eli Lilly and Company ALK Positive Lung Cancer Treatment Product Table 92. Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million) Table 93. Eli Lilly and Company Recent Development Table 94. Takeda Company Details Table 95. Takeda Business Overview Table 96. Takeda ALK Positive Lung Cancer Treatment Product Table 97. Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million) Table 98. Takeda Recent Development Table 99. Beacon Pharma Company Details Table 100. Beacon Pharma Business Overview Table 101. Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2016-2021) & (US$ Million) Table 102. Beacon Pharma Recent Development Table 103. Research Programs/Design for This Report Table 104. Key Data Information from Secondary Sources Table 105. Key Data Information from Primary Sources List of Figures Figure 1. Global ALK Positive Lung Cancer Treatment Market Share by Type: 2020 VS 2027 Figure 2. Crizotinib Features Figure 3. Alectinib Features Figure 4. Ceritinib Features Figure 5. Brigatinib Features Figure 6. Other Features Figure 7. Global ALK Positive Lung Cancer Treatment Market Share by Application: 2020 VS 2027 Figure 8. Hospital Case Studies Figure 9. Clinics Case Studies Figure 10. Other Case Studies Figure 11. ALK Positive Lung Cancer Treatment Report Years Considered Figure 12. Global ALK Positive Lung Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global ALK Positive Lung Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global ALK Positive Lung Cancer Treatment Market Share by Regions: 2020 VS 2027 Figure 15. Global ALK Positive Lung Cancer Treatment Market Share by Regions (2022-2027) Figure 16. Global ALK Positive Lung Cancer Treatment Market Share by Players in 2020 Figure 17. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2020 Figure 18. The Top 10 and 5 Players Market Share by ALK Positive Lung Cancer Treatment Revenue in 2020 Figure 19. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2016-2021) Figure 20. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2022-2027) Figure 21. North America ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America ALK Positive Lung Cancer Treatment Market Share by Type (2016-2027) Figure 23. North America ALK Positive Lung Cancer Treatment Market Share by Application (2016-2027) Figure 24. North America ALK Positive Lung Cancer Treatment Market Share by Country (2016-2027) Figure 25. United States ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe ALK Positive Lung Cancer Treatment Market Share by Type (2016-2027) Figure 29. Europe ALK Positive Lung Cancer Treatment Market Share by Application (2016-2027) Figure 30. Europe ALK Positive Lung Cancer Treatment Market Share by Country (2016-2027) Figure 31. Germany ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific ALK Positive Lung Cancer Treatment Market Share by Type (2016-2027) Figure 39. Asia-Pacific ALK Positive Lung Cancer Treatment Market Share by Application (2016-2027) Figure 40. Asia-Pacific ALK Positive Lung Cancer Treatment Market Share by Region (2016-2027) Figure 41. China ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America ALK Positive Lung Cancer Treatment Market Share by Type (2016-2027) Figure 49. Latin America ALK Positive Lung Cancer Treatment Market Share by Application (2016-2027) Figure 50. Latin America ALK Positive Lung Cancer Treatment Market Share by Country (2016-2027) Figure 51. Mexico ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa ALK Positive Lung Cancer Treatment Market Share by Type (2016-2027) Figure 55. Middle East & Africa ALK Positive Lung Cancer Treatment Market Share by Application (2016-2027) Figure 56. Middle East & Africa ALK Positive Lung Cancer Treatment Market Share by Country (2016-2027) Figure 57. Turkey ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE ALK Positive Lung Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021) Figure 61. Pfizer Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021) Figure 62. Novartis Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021) Figure 63. TP Therapeutics Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021) Figure 64. Bristol-Myers Squibb Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021) Figure 65. Eli Lilly and Company Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021) Figure 66. Takeda Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021) Figure 67. Beacon Pharma Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2016-2021) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

F. Hoffmann-La Roche Pfizer Novartis TP Therapeutics Bristol-Myers Squibb Eli Lilly and Company Takeda Beacon Pharma